DouYu Q4 2025 Earnings Massive EPS Beat Yet Stock Declines Amid Revenue Uncertainty OPCH Q1 2026 Earnings EPS Beats Estimates by 546 Amid Revenue Data Unavailability XPON Q2 2025 Earnings EPS Beats Estimates by 307 Despite Absent Revenue Data Vor Biopharma Q1 2026 Earnings Wide EPS Miss Sends Stock Down 47 Amid Ongoing Clinical Development PEPG Q1 2026 Earnings NarrowerThanExpected Loss Highlights Cost Discipline MBIN Q1 2026 Earnings EPS Beats Estimates by 5 Stock Declines Modestly